Impact of adjuvant therapy on outcomes after curative-intent resection for distal cholangiocarcinoma.

Jing-Jing HouShishir K MaithelSharon M WeberGeorge PoultsidesChristopher L WolfgangRyan C FieldsJin HeCharles ScogginsKamron IdreesPerry ShenXu-Feng ZhangTimothy M Pawlik

Published in: Journal of surgical oncology (2022)

AT was commonly utilized among patients with DCC. Patients with more advanced disease, including the presence of PNI or LNM, benefited the most from AT with improved long-term outcomes among this subset of patients.

Keyphrases

end stage renal disease
prognostic factors
ejection fraction
newly diagnosed
chronic kidney disease
rectal cancer